AJH92
5 minutes ago
Share Structure - Updated February 7, 2025
Transfer Agent Verified
No change - no dilution
All future acquisitions will use Preferred Z shares
Authorized Shares: 7,000,000,000
Outstanding Shares: 3,501,977
Rest
Lonewolf1
13 minutes ago
APLT's strategy is to present to the FDA in Q1 of 2025 their results style="caret-color: rgb(35, 42, 49); color: rgba(35, 42, 49, 1); font-family: YahooSans-Regular, sans-serif; font-size: 17px; background-color: rgba(255, 255, 255, 1)"Galactosemia, SORD Deficiency, and PMM2-CDG. The company is al